ABSTRACT
BACKGROUND: Vivax malaria reemerged in the Republic of Korea in 1993. Since 1993, many cases with malaria have been reported. But due to the antimalarial activities including chemoprophylaxis and repellents, the annual incidence of malaria has been decreased. Antimalarial chemoprophylaxis is effective to control disease, but will facilitate the spread of drug-resistance or drug-tolerance. Thus, it is needed to analyze the effect of treatment outcome. METHODS: We analyzed the patients diagnosed as vivax malaria who readmitted in military hospital from 1997 to 2003. All cases were confirmed as malaria by peripheral blood smear in military hospital. RESULTS: Forty-five cases were observed in second attack and three cases were observed in third attack. All cases were vivax malaria with fever, and tertian fever developed in 25 cases (55.5%) in first attack, 22 cases (48.8%) in second attack. Various distribution of the interval between first attack remission and second attack was observed (from 8 days to 37 months). Of the all cases, 41 cases (91.1%) developed malaria between May and October in first attack, 39 cases (86.6%) in second attack. Readmission rate were 0.68%. CONCLUSION: We observed that only 45 of 6,566 (0.68%) cases were readmitted. The treatment of vivax malaria in Korea Army is effective in controlling malaria and should be cotinued. But continued surveillance with veterans and with or without chemoprophylaxis are warranted to eliminate the spread of the disease.
Subject(s)
Humans , Chemoprevention , Fever , Hospitals, Military , Incidence , Korea , Malaria , Malaria, Vivax , Military Personnel , Patient Readmission , Plasmodium vivax , Republic of Korea , Treatment Outcome , VeteransABSTRACT
Neurilemmoma is a neoplasm arising from Schwann cells. It is usually solitary and may be benign or malignant, solid or cystic, encapsulated or diffuse. It rarely occurs in the retroperitoneum. We report one case of retroperitoneal neurilemmoma with review of the literatures.
Subject(s)
Neurilemmoma , Schwann CellsABSTRACT
Primary malignancies of the urethra are uncommon and prognosis is poor except in patients with disease that is limited to the anterior urethra. Urethral tumors in the male patient comprise less then one percent of all urologic malignancies. We experienced a case of malignant urethral tumor(transitional cell carcinoma). Herein we report this case with brief review of the literatures.
Subject(s)
Humans , Male , Prognosis , UrethraABSTRACT
Primary malignancies of the urethra are uncommon and prognosis is poor except in patients with disease that is limited to the anterior urethra. Urethral tumors in the male patient comprise less then one percent of all urologic malignancies. We experienced a case of malignant urethral tumor(transitional cell carcinoma). Herein we report this case with brief review of the literatures.
Subject(s)
Humans , Male , Prognosis , UrethraABSTRACT
An erectiometer for the measurement of sleep erections is described. Clinical data using the erectiometer indicates that it processes a significant potential for valid measurement of the circumfernetial increase that may occur during sleep. Because of its reliability, simplicity, reproducible data and low cost the erectiometer is proposed as a screening procedure or as a diagnostic alternative when sleep laboratory facilities are not feasible practically.
Subject(s)
Mass ScreeningABSTRACT
A giant hydronephrosis caused by ureteropelvic junction stricture in a 16-month-old male infant was presented. After the size and volume of giant hydronephrosis were estimated by retrograde pyelography, nephrectomy was performed. We report this case with review of literatures.